Progress in Oncolytic Virotherapy for Treatment of Thyroid Malignant Neoplasm

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/preaccept-1887479723143655
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances

Oncolytic Virotherapy
2015English

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2012English

Oncolytic Virotherapy

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Oncolytic Virotherapy for Malignant Glioma: Translating Laboratory Insights Into Clinical Practice

Frontiers in Oncology
Cancer ResearchOncology
2013English

Delivery and Biosafety of Oncolytic Virotherapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Cancer immunology research
Cancer ResearchImmunology
2018English

Emerging Role of Natural Killer Cells in Oncolytic Virotherapy

ImmunoTargets and Therapy
AllergyImmunology
2015English

Oncolytic Virotherapy as an Immunotherapeutic Strategy for Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2017English

Malignant Thyroid-Type Papillary Neoplasm in Struma Ovarii: A Case Report

Cureus
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy